- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01605656
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cognitive Interviews:
If you agree to take part in this study, you will be take part in a cognitive interview. A cognitive interview is a process that helps researchers test out questions on a few people so the questions can improved.
During the interview, a research staff member will use a questionnaire to ask you about many different health and social topics.
As the questions are read to you, please answer them, but also tell the research staff member what you're thinking. Please try to think out loud and say everything that comes to mind, whether it seems important or not. You will be asked how you came up with your answers and how you understood the questions. If any question seems unclear or hard to answer, please tell the research staff member. A member of the research staff will be taking notes during the interview.
The cognitive interview should take up to 45 minutes to complete.
Length of Study:
Your participation in this study will be over after you complete the cognitive interview.
This is an investigational study.
Up to 10 participants will be enrolled in this part of the study. All will take part at Thomas Street Health Center.
Phase I:
If you agree to take part in this study, you will complete a questionnaire about your age, education level, income, and general health behaviors. This questionnaire should take about 20 minutes to complete.
After completing the questionnaire, you will take part in a focus group discussion with other women who are patients at Thomas Street Health Center. There will be up to 8 women in each of the 5 groups.
In the focus group, you will be asked questions about personal and clinic-related factors that might make it more difficult to receive pap smear screenings. You will also be asked to discuss what might make it easier or encourage women to receive pap smear screenings. The focus group discussion should last 60-90 minutes.
The information discussed in the focus groups may be sensitive, so you will be asked to keep the information discussed in the group private.
Length of Study:
Your participation in this study will be over after you complete the questionnaire and participate in the focus group discussion.
This is an investigational study.
Up to 40 participants will be enrolled in this part of the study. All will take part at Thomas Street Health Center.
Phase II:
If you agree to take part in this study, you will complete 2 questionnaires. The first questionnaire will ask about your age, education level, income, and general health behaviors. This questionnaire should take about 20 minutes to complete.
The second questionnaire will ask about many different health and social topics. This questionnaire should take up to 45 minutes to complete.
Length of Study:
Your participation in this study will be over after you complete the 2 questionnaires.
This is an investigational study.
Up to 200 participants will be enrolled in this part of the study. All will take part at Thomas Street Health Center.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77009
- Thomas Street Health Center, Harris County Hospital District
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- English speaking
- Patient receiving HIV/AIDS care at Thomas Street Health Center
- Female
- 18 years of age or older
- Able to provide written informed consent to participate
Exclusion Criteria:
1) Physically deemed ineligible based on medical (HIV related or other condition) or psychiatric condition
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Focus Groups + Interviews + Questionnaires
HIV-positive women recruited from the population of individuals seeking care at Thomas Street Health Center (TSHC) of the Harris County Hospital District (HCHD).
|
A research staff member will use a questionnaire to ask about many different health and social topics.
The cognitive interview should take up to 45 minutes to complete.
Phase I: Completion of a questionnaire about age, education level, income, and general health behaviors. This questionnaire should take about 20 minutes to complete. Phase II: Completion of 2 questionnaires. The first questionnaire will ask about age, education level, income, and general health behaviors. This questionnaire should take about 20 minutes to complete. The second questionnaire will ask about many different health and social topics. This questionnaire should take up to 45 minutes to complete.
Other Names:
Phase I: There will be up to 8 women in each of the 5 focus groups. Participants asked questions about personal and clinic-related factors that might make it more difficult to receive pap smear screenings. Participants also asked to discuss what might make it easier or encourage women to receive pap smear screenings. The focus group discussion should last 60-90 minutes. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HIV Positive Women's Perceived Barriers to Cervical Cancer Screening
Time Frame: 1 day
|
Participants rank Nominal Group Technique (NGT) items (cervical cancer screening barriers and strategies to improve screening) from 1-5 (1-least important: 5-most important).
Once two coders have calculated rankings, the 5 items receiving the highest number of points will be deemed the 5 barriers to cervical cancer screening.
Similarly, the 5 strategy-based items receiving highest number of points will be deemed essential strategies to improving cervical cancer screening at Thomas Street Health Center (TSHC).
|
1 day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Damon Vidrine, MS, DRPH, BA, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Neoplasms
- Urogenital Neoplasms
- Neoplasms by Site
- Uterine Neoplasms
- Genital Neoplasms, Female
- Uterine Cervical Diseases
- Uterine Diseases
- HIV Infections
- Uterine Cervical Neoplasms
- HIV Seropositivity
Other Study ID Numbers
- 2012-0240
- R25T CA57730 (Registry Identifier: NCI)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Prevention
-
University of Puerto Rico Comprehensive Cancer...CompletedBreast Cancer Prevention | Colorectal Cancer Prevention | Cervical Cancer PreventionPuerto Rico
-
German Cancer Research CenterUniversity of Music, Drama, and Media HannoverCompleted
-
The University of Texas Health Science Center,...Cancer Prevention Research Institute of TexasRecruiting
-
German Cancer Research CenterUniversity of Music, Drama, and Media HannoverCompleted
-
M.D. Anderson Cancer CenterActive, not recruitingCancer PreventionUnited States
-
AshtaYoga, LLCColumbia University; University Of Nigeria Teaching Hospital; Project PINKBLUE... and other collaboratorsNot yet recruitingStep up to Health, Nigeria! Impact of 2022 World Cancer Day Walk on Health Behaviors Among NigeriansCancer PreventionNigeria
-
Case Comprehensive Cancer CenterCompleted
-
IWK Health CentreLaval University; Canadian Association of Fire ChiefsActive, not recruiting
-
HealthPartners InstituteCompleted
-
AshtaYoga, LLCColumbia University; University Of Nigeria Teaching Hospital; Project PINKBLUE... and other collaboratorsCompletedCancer PreventionNigeria
Clinical Trials on Cognitive Interview
-
Duke UniversityFood and Drug Administration (FDA)Recruiting
-
Washington University School of MedicineCompleted
-
University of Colorado, DenverNational Cancer Institute (NCI)RecruitingMetastatic Colorectal CancerUnited States
-
Northwestern UniversityRegeneron PharmaceuticalsCompletedPsoriasis | Atopic Dermatitis | IchthyosisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedCancer | Depression, Anxiety | SurvivorshipUnited States
-
VA Office of Research and DevelopmentCompletedDiabetes | Self-Management | Diabetes Distress | VeteranUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Northwestern... and other collaboratorsCompletedHIV Infection | High Grade Anal Canal Squamous Intraepithelial NeoplasiaUnited States
-
University of the West of EnglandJohns Hopkins University; University of PittsburghRecruitingGastrointestinal Diseases | Respiratory Disease | Immune System Disorder | Inflammatory Disease | Dermatologic DiseaseUnited Kingdom
-
University Hospital, AngersCompletedPresymptomatic Huntington DiseaseFrance
-
Memorial Sloan Kettering Cancer CenterCompleted